SUPPLEMENTAL DISCLOSURE WITH RESPECT TO CASH FLOWS

9 Months Ended

Apr. 30, 2025

Supplemental Cash Flow Elements [Abstract]

SUPPLEMENTAL DISCLOSURE WITH RESPECT TO CASH FLOWS [Text Block]

13. SUPPLEMENTAL DISCLOSURE WITH RESPECT TO CASH FLOWS

During the nine-month periods ended April  30, 2025 and 2024, the Company had the following non-cash financing and investing activities:

For the period ended April 30, 2025:

a) The Company accrued $220,708 of interest expense as part of the outstanding balance of loan payable and line of credit.

b) The Company issued a total of 1,700,000 share purchase warrants, as consideration for loan extension, entitling the holder to acquire one share at an exercise price of US$0.115 until September 12, 2028 with a total fair value of $154,351.

c) The Company issued 2,882,514 share purchase warrants for a secured loan agreement entitling the holder to acquire one share at an exercise price of US$0.1735 until October 10, 2028 with a total fair value of $334,423.

d)  The Company allocated $28,061 to deferred financing asset.

For the period ended April 30, 2024:

a) The Company accrued $192,230 of interest expense as part of the outstanding balance of loan payable.